-
CTN 043: Whey Protein Supplementation
Whey Protein Supplementation in HIV-Infected Children: A Pilot Study
-
CTN 034: Erythropoietin deficiency in children
Anemia Among HIV-infected Children Receiving Zidovudine: Identification of Markers of Erythropoietin Deficiency and Likelihood of Response to Exogenous Erythropoietin
-
CTN 033: Rgp 160 vaccine (VaxSyn)
Active Immunization of Patients with HIV Infection: The Study of the Effect of VaxSyn on Progression of Immunodeficiency (gp160): Trial results
-
CTN 024: Rifabutin for prevention of MAC
Rifabutin Therapy for the Prevention of MAC in Patients with AIDS
-
CTN 020: Itraconazole, ketoconazole
Clinical Evaluation of Itraconazole vs. Ketoconazole in HIV+ Patients with Oropharyngeal and/or Oesophageal Candidiasis
-
CTN 016: Acemennan
A Pilot Controlled Double Blind Study of Acemennan in Patients Receiving AZT for the Treatment of Advanced HIV Disease
-
CTN 014: AZT, Intron A for KS
Phase III Study of AZT with Two Dose Levels of Intron-A in Treatment of AIDS-Related Kaposi’s Sarcoma
-
CTN 010: Chemotherapy for MAC
A Prospective, Randomized Comparative Trial of Combination Chemotherapy of MAC Infection in AIDS: Trial results
-
CTN 004: Clindamycin-primaquine, TMP-SMX for PCP
Clindamycin, Primaquine vs.Trimethoprim Sulphamethoxazole
-
CTN 003: Multi-centre AZT trial
Multi-centre AZT Trial (MCAT): Trial results This study described the rate of in vitro (in the test tube) resistance of HIV to AZT and how resistance could point to subsequent disease progression.
-
CTN 002: ddI, continued AZT
Double Blind Comparison of ddI and Continued Zidovudine (AZT) in Therapy of Patients with HIV-Related Immune Suppression: Trial results
-
CTNPT 001: Fracture case-control study in HIV
A case-control study of novel bone imaging techniques and plasma markers in HIV-infected persons with or without fragility fractures
Careers
Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.v
Learn More